Nordic Capital

News, insights, analysis and data

Nordic Capital overview

Stories about Nordic Capital

Picture of the Company

Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m

LEO Pharma, which the release describes as a global leader in medical dermatology, serves close to 100 million patients in more than 70 countries annually.

Picture of the Company

Nordic Capital to carve out BWXT's medical business in $800m transaction

Nordic expects to scale BWXT's capabilties and market presense in radiopharmaceuticals.

Picture of the Company

Nordic Capital to sell life sciences software provider ArisGlobal

ArisGlobal’s client base includes many pharmaceutical and biotech companies as well as regulatory authorities.

Picture of the Company

3 reasons PE is targeting European water treatment

'The scale of investment required across water and wastewater infrastructure is significant, while the sector faces constraints in terms of skilled labor, specialist equipment and engineering expertise,' Nordic Capital's Andreas Näsvik told PE Hub.

Picture of the Company

How a decade of pharma digitalization drove Nordic's $8.9bn sale of Clario to Thermo Scientific

'The sale to Thermo Fisher Scientific was the single biggest full exit in private equity globally announced last year,' Daniel Berglund, partner and head of healthcare at Nordic Capital, told PE Hub.

Picture of the Company

Nordic Capital to acquire water infrastructure biz Flowa from Vestum

Flowa provides water and wastewater infrastructure services across the UK and the Nordics.

Picture of the Company

PE targets pathology assets: 5 deals

Astorg, Cinven, Nordic Capital, Consonance and Pike Street are among the firms pursuing transactions in pathology.

Picture of the Company

PE investor group completes sale of clinical trial data firm Clario to Thermo Fisher for $8.9bn

The sellers were an investor group led by Astorg, Nordic Capital, Novo Holdings and Cinven.

Nordic Capital contact information

Offices

marker iconMäster Samuelsgatan 21, 9th floor, Stockholm, 111 44, Sweden
Showing 1 of 10 Nordic Capital offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMs. Jeeyeon Hwang
Job titleExecutive Director, Investor Relations – Asia Pacific
LocationStockholm, Sweden
Emaillock image-----
Key Contact
user imageMr. Daniel Kanak
Job titlePartner and Global Head of Investor Relations
LocationLondon, United Kingdom
Emaillock image---------
Key Contact
user imageMr. Kyle Mallen
Job titleManaging Director, Investor Relations, Middle East
LocationLondon, United Kingdom
Emaillock image-----------
Key Contact
user imageMr. Tony Rochford
Job titleManaging Director, Investor Relations
LocationLondon, United Kingdom
Emaillock image-----------

Nordic Capital funds managed

Funds in market: 5

FundFund sizeOpen dateStrategy
Fund sizelock image----------
Open dateSep 2026
Strategylock image--------
Fund sizelock image----------
Open dateJan 2026
Strategylock image------
Fund sizelock image------
Open dateDec 2025
Strategylock image------

Closed funds: 16

FundFund sizeClose dateStrategy
Fund sizelock image--------
Close dateDec 2024
Strategylock image--------
Fund sizelock image-------
Close dateOct 2022
Strategylock image-----
Fund sizelock image-------
Close dateMar 2022
Strategylock image-----------

Stories that mention Nordic Capital

Medtech moves into private equity’s sweet spot

Lower valuations, corporate carve-outs and resilience to AI disruption are opening up medtech to buyout firms after years of limited access.

Where’s the ROI in AI?

In theory, artificial intelligence should slash costs and ramp up productivity at the GP level, but achieving a return on that investment is proving to be a slow process.

Side Letter: Secondaries déjà vu

In today's edition, Secondaries volumes break another record; Europe amasses a war chest (quite literally); Astorg is racking up exits.

Astorg’s Judith Charpentier: Mid-market focus will maximize exit choices

While the valuation gap is ‘slightly reducing,’ the volatile macro backdrop makes exit optionality even more important, Astorg’s co-managing partner told PE Hub.

PEI 300: The shifts that are changing Europe

Mega-funds, market bifurcation and a resurgent investor base are reshaping the continent’s private equity landscape.

Future 40 Leaders – 2026: Dealmakers

Meet the up-and-coming dealmakers featured in our Future 40 list for 2026.

Sector Spotlight: Wealth, insurance and fintech drive thriving PE-backed financial services M&A

PE Hub spoke with senior private equity dealmakers from Carlyle, Charlesbank, GTCR, Motive Partners, Stone Point Capital and Warburg Pincus about the trends driving financial services deals.